Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains

A. S. Bayer; C. Li; M. Ing

Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains

A. S. Bayer, C. Li, M. Ing

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	405
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	25
Issue number	2
State	Published - 1997

ASJC Scopus Subject Areas

Microbiology (medical)
Infectious Diseases

OpenUrl availability

Full text

Cite this

@article{b8eaed2e191f45a288e2d22d383aef30,

title = "Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains",

author = "Bayer, {A. S.} and C. Li and M. Ing",

year = "1997",

language = "English",

volume = "25",

pages = "405",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "2",

}

TY - JOUR

T1 - Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains

AU - Bayer, A. S.

AU - Li, C.

AU - Ing, M.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=33748202096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748202096&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748202096

SN - 1058-4838

VL - 25

SP - 405

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains

ASJC Scopus Subject Areas

OpenUrl availability

Other files and links

Cite this